Aim Single-incision laparoscopic (SIL) surgery is expanding, but its benefits, efficacy and safety compared with conventional laparoscopic (CL) surgery remain unclear. This pilot study examined clinical outcomes and biochemical markers of inflammation for colorectal resections by SIL and CL in a randomized controlled pilot trial.
Results There was no difference in age, gender, body mass index, indications and site of surgery, American Society of Anesthesiologists grade or incidence of previous surgery between the groups. Except for one conversion from SIL to open surgery, surgery was completed as intended. No difference between SIL and CL was found for operating time [median 130 (72-220) vs 130 (90-317) min, respectively, P = 0.528], LoS [median 4 (3-8) vs 4 (2-19)days, P = 0.888] and time to first flatus [2 (1-4) vs 2 (1-5) days, P = 0.374]. The combined length of scars was significantly shorter for SIL [4 (2-18 ) vs 7 (5-8) cm, P < 0.001]; in each group, four postoperative complications occurred (16%). Postoperative pain scores were similar [mean 7.67 (interquartile range 4) vs 7.25 (interquartile range 3.75), P = 0.835] to day 3. EQ5D-VAS was no different for both groups at discharge [72. 5 (40-90 ) vs 70 (30-100), P = 0.673] but slightly higher for CL at 3 months [79 (45-100) vs 90 (50-100), P = 0.033].The IL-6, IL-8 and CRP levels between both groups showed similar peaks and no significant differences.
Introduction
Conventional (multi-port) laparoscopic surgery (CL) is the gold-standard approach to colorectal resection, as it has demonstrable short-term benefits over open surgery [1] and it is not oncologically inferior to open surgery [2, 3] . Over the last decade, surgeons have pushed the concept of colorectal single-incision laparoscopic surgery (SIL) [4] [5] [6] [7] [8] [9] [10] [11] [12] as it has a perceived cosmetic benefit, given that the specimen extraction in CL requires an extension to one incision site. In recent reviews on SIL colorectal surgery there have been suggestions that it may have objective clinical benefits over CL, including reduced blood loss, shorter length of hospital stay (LoS) and earlier return of bowel function [13, 14] . However, much of the evidence is based on observational data from case-control series and comparative studies of low quality [15] , with a paucity of randomized controlled trials comparing SIL and CL colorectal surgery [16, 17] . Regarding the physiological immune response to surgical trauma, as has been examined in comparisons between conventional laparoscopic and open surgery [18, 19] , only one randomized trial focusing on rectal surgery has been published recently [20] . To determine the short-term outcomes and physiological stress response to SIL in colon and rectal surgery, we conducted this trial using CL in a control group. The study was designed as a pilot study to inform the feasibility of a potential future large-scale randomized controlled trial.
Method
The study was conducted within a single institution by three laparoscopic colorectal consultant surgeons, all of whom completed a national surgical training programme including significant laparoscopic colorectal experience, and had performed a minimum of 10 SIL colorectal procedures prior to participation; one surgeon is a national laparoscopic trainer. The unit has a long history of laparoscopic colorectal surgery with more than 80% of colorectal resections carried out laparoscopically and is a training centre for laparoscopic surgery as well as a tertiary referral centre for early rectal cancers. The randomized, single-blinded controlled trial was registered with Clinical Trials (NCT01626963) and approved by the local research and development unit (SUR-089) and the Regional Ethics Committee (Yorkshire and The Humber -Bradford Leeds Research Ethics Committee; 13-YH-0241). Financial support for the additional laboratory investigations was given by the local research and development research incentive fund. The trial was carried out in line with good clinical practice (GCP), and reporting follows the CONSORT 2010 guidelines extension to randomized pilot and feasibility trials [21] .
Fifty patients were randomized to one of two equal-sized groups to undergo surgery either by singleincision laparoscopic access (SIL) or by conventional multi-port laparoscopic access (CL). As the primary outcome, based on our own previous work, operative time was determined as the most likely to yield a difference [22] . As the clinically most relevant outcome, LoS was included as second primary end-point. The null hypothesis for all end-points of analysis was that there is no difference in outcomes. Secondary outcomes included conversion to open surgery, complication rates, overall length of scars, twice-daily pain scores, cumulative consumption of analgesia during the first 3 days, and EQ-5D quality-of-life questionnaires [23] at baseline, discharge from hospital and 3 months from surgery. Inflammatory response was measured by C-reactive protein (CRP), and interleukin-6 (IL-6) and IL-8 levels at induction of anaesthesia (baseline), and at 2, 6, 24 and 72 h from surgery.
Patients
Inclusion criteria were age ≥ 18 years, capacity to give informed consent and planned elective colorectal resection for benign or malignant disease. Patients were excluded if they had had multiple laparotomies previously or if open surgery was required from the outset. Eligible patients were approached in the outpatient department once the decision to proceed with surgical resection was made; they were given the participant information leaflet about the research study, explaining both SIL and CL operations as well as the study methodology. All patients were given at least 48 h to decide whether to participate in this research.
Following informed consent for study participation and surgery, patients completed the EQ-5D questionnaire at baseline. Patients were randomized to either SIL or CL using computer-generated number allocation, and the operating surgical team was given information on the allocated surgical access at the time of anaesthetic induction.
Surgical access and procedure
In most cases, the incision used in the SIL group was trans-umbilical, whilst the CL group had incisions placed as per the individual surgeon's preference for the planned resection, with the specimen extraction site either in the umbilicus or through a lateral port site. The two SIL access devices used in the study were the GelPointâ (Applied Medical, Rancho Santa Margarita, CA92688, California, USA) and the OctoPortâ (DalimsurgNET Co. Ltd., Yangcheon-ro, Gangseo-gu, Seoul, South Korea). In the CL group, standard disposable 12-mm and 5-mm trocars were used, employing cut-down techniques or optical trocars for initial entrance to the abdominal cavity. All surgeons follow the preferred medial-to-lateral mobilization technique if possible, with selective mobilization of the splenic flexure in left-sided resections. Postoperatively, the abdomen was covered with a large dressing to enable sufficient blinding to the patient, nursing staff and the research nurse in a methodology similar to that used in the EnROL trial [24] ; the dressing was kept in place for 5 days, or until discharge from hospital. If inspection of the wound was required for clinical reasons during this period, nursing staff were instructed to make sure the patient remained blinded. Participants were asked during their period of blinding which procedure they thought was done, and about their reasons for believing this. Patients were managed within the principles of an enhanced recovery protocol, with no purgative bowel cleansing prior to surgery, carbohydrate loading, early commencement of oral diet, early mobilization and a target-date for discharge on day 4.
During hospital stay and for a 30-day period, adverse events were collected prospectively. Complications were graded according to the Clavien-Dindo classification [25] . For follow-up, the EQ-5D was completed by the patients at discharge and then at 3 months' follow-up with the research nurse.
Anaesthesia and pain management
At induction of anaesthesia, all patients received antibiotic prophylaxis (single intravenous dose of cefuroxime 1.5 g and metronidazole 500 mg unless there was a known allergy), followed postoperatively by three doses of cefuroxime 750 mg and metronidazole 500 mg. All patients underwent general anaesthesia according to the anaesthetist's practice; epidural catheters were not used, and patients received a transversus abdominis plane block [26] with 40 ml bupivacine 0.25% at the end of surgery. All patients received analgesia as required, with 6-hourly intravenous or oral paracetamol (1 g), and given patientcontrolled analgesia (PCA) with morphine via an electronic device set to a 1-mg bolus with a lock-out time of 5 min. The total amount of nonsteroidal medication and opiates/ opioids used was recorded on a daily basis (first 24 h, 24-48 h, 48-72 h and 72-96 h from surgery). Some patients received fentanyl or other opioid medication in place or in addition to morphine; the equivalent dose to intravenous morphine was calculated based on the 0% cross-tolerance effect (http://clincalc.com/opioids). The patient's pain scores were recorded on a twice-daily basis using a Likert visual analogue scale (VAS) from 0 to 10.
Blood sampling and enzyme-linked immunosorbent assay for IL-6 and IL-8
The inflammatory markers CRP, IL-6 and IL-8 were measured from venous blood taken just prior to the induction of anaesthesia and postoperatively at 2, 6, 24 and 72 h from the conclusion of surgery. CRP was tested through the hospital's laboratory and expressed as mg/l. The blood for IL-6 and IL-8 was drawn in EDTA collection tubes (Sarstedt Ltd, Leicester, UK) and initially refrigerated at +2°C until centrifugation at 2000 g for 15 min during the following working day. It was then stored as small aliquots in a À80°C freezer for batch analysis by enzyme-linked immunosorbent assay (ELISA) in a 96-well plate. Samples and standards were analysed in duplicate and 40 samples were run at a time, ensuring that all samples from a patient were run on the same assay (eight patients with five blood samples each). IL-6 and IL-8 plasma concentrations were measured using commercial ELISA kits following the assay protocol (Quantikine human IL-6 ELISA and High Sensitivity Quantikine human IL-8 ELISA; R&D Systems, Abingdon, UK). The optical density of each well was determined using a microplate reader set at 450 nm with a correction wavelength set at 540 nm. The microplate reader was linked to Revelation software to determine the mean antigen concentrations (Dynatech Laboratories, Billinghurst, UK). Results were expressed as picograms per millilitre (pg/ml).
Data capture and statistical analysis
All study data were stored with adherence to the data protection principles of the National Health Service England. Data were entered and some graphics were created in Microsoftâ Excel 2003 (Microsoft Corporation, California, USA), and statistical analysis carried out with SPSSâ version 20 (IBMâ SPSSâ, Armonk, New York, USA). Data collected from each participant included gender, age, weight and height, body mass index(BMI), previous surgical history, co-morbidity [American Society of Anesthesiologists (ASA) grade [27] ], indication for surgery, operative procedure, surgical access group (randomization), total length of incisions, operating time, blood loss, intra-operative and postoperative complications, disposable equipment used, EQ-5D, pain scores, analgesia used, LoS, time to first flatus and bowel movement, and CRP and IL-6/IL-8 levels. Any serious adverse events (SAE) were also recorded, including death, life-threatening complication, further hospitalization, persistent/significant disability/ incapacity, and reported according to the CONSORT recommendations [28] .
All relevant variables were analysed by the intentionto-treat principle. Significance was taken at the P ≤ 0.05 level. Fig. 2b ].
All but one of the operations were carried out according to the intention to treat, with one (4.0%) conversion to open surgery in the SIL group due to an unexpected extensive disease process. Median blood loss across both groups was 40 ml, with a range from 0 to 800 ml. Other than the inherent difference in the number of incisions, the only difference between the groups was found in the combined length of incisions, which was significantly smaller for SIL than for CL [median (range) SIL, 4 (2-18) cm; CL, 7 (5-8) cm; MannWhitney U-test, P < 0.001], including conversion to open surgery. In each group, four (16.0%) patients had complications, including four cases classified as SAE; operative and early postoperative data are presented in Table 2 .
Pain scores and analgesia requirements
Pain scores were recorded twice-daily for the first 3 days after surgery; there were no statistical differences in the mean pain levels during normal postoperative behaviour and mobilization between SIL and CL at any time point (Fig. 3a) . Both groups showed similar requirements for on-request delivered opiate medication (Fig. 3b) .
CRP response and inflammatory cytokines IL-6 and IL-8
The acute phase protein CRP and inflammatory cytokines IL-6 and IL-8 were examined twice: first comparing their absolute values at the given time-points and second in proportion to their baseline values measured at induction of anaesthesia. In all analyses there was no statistical difference in the inflammatory response between SIL and CL groups (CRP, Fig. 4 ; IL-6 and IL-8, Fig. 5 ).
Subjective patient outcomes
All patients were asked during blinding to indicate which procedure they thought had been performed; only 10/23 (43.5%) SIL patients correctly identified the surgical access (one patient did not state his opinion, and one patient was 'unblinded' by an attending staff member); only 11/24 (45.8%) CL patients identified their group correctly (one patient did not state his opinion).
There were no significant differences in the individual domains of the EQ-5D assessment between both groups; however, baseline score for the EQ-5D VAS 0-100 was higher at baseline and 3 months' follow-up in the CL group, with similar values at discharge from hospital: median (range) EQ-5D at baseline: SIL 75 (5-100), CL 85 (45-100), Mann-Whitney U-test, P = 0.016; EQ-5D at discharge: SIL 72.5 (40-90), CL 70 (30-100), P = 0.673; EQ-5D at 3 months: SIL 79 (45-100); CL 90 (50-100), P = 0.033.
Discussion
This randomized, single-blinded study did not find any significant differences between SIL and CL colorectal resections for their respective clinical outcomes. Previously published work on SIL colorectal surgery has been largely based on case series and historically comparative, observational and nonrandomized studies, with a paucity of randomized data. Our findings have not confirmed the benefits observed in two previously published meta-analyses, namely a reduction in the time to bowel function and LoS [13, 14] or blood loss [13] . In another comparative review, SIL outcomes have been equivalent to CL in the selective setting of colorectal cancer [29] , and a review of two randomized trials had suggested a benefit on LoS [15] .
The published randomized controlled data appeared to show a benefit of SIL on postoperative pain, as reported by Poon et al. [16] in their highly selective trial on colorectal neoplasms including small cancers and adenomas, and by Bulut et al. [20] , for rectal cancer resections; this particular benefit has not been confirmed in our findings. The design of our study was very similar to that of Bulut's trial [20] ; however, we did not apply limitations on indications, body weight or, if surgery was carried out for cancer, on tumour size. We did also not prescribe a specific regimen for peri-operative anaesthesia, as a variety of anaesthetists were involved and we specifically did not attempt to restrict their own routine practice. It is noteworthy that, in contrast to our patients, all patients in Bulut's study received epidural analgesia for 72 h, possibly explaining their longer postoperative LoS (median 7 days for SIL and 8 days for CL) compared with our patients. In laparoscopic surgery there is some doubt that epidural analgesia provides sufficient benefit [30] , and it may even prolong recovery [31] ; we do routinely not employ epidural analgesia in our laparoscopic practice. However, whilst we did not observe differences between pain levels between the two groups, our pain scores were numerically higher than those observed by Bulut. However, direct comparison of the studies for a subjective outcome measure is difficult as this may be the result of differences in recording, explanation of the pain scale or other patient-level factors.
The Danish trial [20] included only rectal cancer patients, in whom the formation of an end-colostomy or defunctioning stoma is more prevalent, and SIL access was often placed at the site of the planned stoma. In our study, we most often utilized the umbilicus as the access point. Bulut et al. [20] postulate that the reduced number and smaller combined length of scars could be responsible for the advantage of SIL. Given the wider range of procedures and anatomical location Regarding the longer LoS in Bulut's trial, the quite substantial morbidity, including a high anastomotic leak rate, may well contribute to their findings. Another important difference from Bulut et al.'s study design was our adherence to blinding: to avoid a placebo effect, all patients were given a large abdominal dressing covering the area that would include all port-sites in CL; interestingly, patients' subjective perceptions of where and how many incisions were used had a positive predictive value of less than 50%. The present study is only the second trial to include markers of physiological stress response in comparison of SIL and CL colorectal surgery. Acute phase proteins and cytokine release is the natural response to surgical trauma. As a nonspecific marker of acute phase activation, CRP increases after 4-12 h from surgery, peaks between 24 and 72 h, and remains elevated up to 2 weeks, unless complications occur [32] . IL-6 is an almost immediately released, direct-proportional marker of the extent of surgical trauma [33] , and is regarded as reliable cytokine marker for the extent of surgical trauma [19] . Significant elevation of CRP, IL-1, IL-6 and IL-8 levels is expected following major surgery, both open and laparoscopic; however, the relative importance of local peritoneal trauma by carbon dioxide insufflation in laparoscopic surgery is not well studied [34] . Indeed, amongst a subgroup of patients treated within the COLOR II trial, comparing outcomes for CL and open rectal resections, Veenhof et al. demonstrated that the inflammatory response markers were largely similar for both groups, with the exception of lower levels of IL-6 during the immediate postoperative period in laparoscopic surgery [19] . It is therefore unsurprising that we found no differences in the systemic markers of stress response, a result that supports the findings of Bulut et al. [20] . Equivalence in the physiological stress response has also been demonstrated for SIL and CL cholecystectomy [35] .
The complication rates after both SIL and CL surgery in our study are acceptable, although three cases classified as Clavien-Dindo III occurred. With the exception of one port-site hernia in a SIL patient, none of the complications were directly attributable to the operative procedure and none were reasons to stop the trial. Regarding the development of incisional hernia in CL surgery, the incidence is known to be highest for colorectal patients (1.5%) when compared with other operations [36] , and was found to be higher for SIL compared with CL in a review of 19 randomized controlled trials on a variety of trans-umbilical SIL procedures, of which many did not require significant extension to the access incision [37] .
The difference in the patients' quality of life ratings seen in this study is of interest. At 3 months from surgery, the patients in the SIL group had a significantly lower EQ-5D score than those in the CL group; however, this was a return to the difference seen at baseline. The reasons for this are unclear -one potential explanation could be the higher proportion of patients rated ASA III and the lower proportion rate as ASA I in the SIL group, although this disparity by itself did not achieve statistical significance.
Our trial did not focus on cancer patients; however, there was no indication that surgical resection margins were compromised. Two recently published, large nonrandomized, case-matched studies on predominantly right-colonic SIL cancer resections [38] and large T4 colon cancers operated by SIL access [39] did not reveal any immediate or medium-term oncological compromise.
By keeping exclusions from the study to a minimum, we tried to keep the risk of selection bias to a minimum, and reflect as much as possible our general patient population. Most patients who declined participation in the randomization either chose SIL as their preferred approach or did not want to participate in research that affected their right to decide their treatment.
Initially, SIL colorectal surgery was associated with higher cost than CL [40] . In our experience, the equivalence of the relevant end-points (operative time, LoS, analgesia requirements), together with the similar cost for the SIL device compared with the usual requirement of four disposable laparoscopic ports and a wound protection device, would indicate that there is no significant financial burden on the healthcare system. Our study is unable to capture any effect related to the learning curve because all operating surgeons were experienced in SIL colorectal surgery. Little is known about the learning curve, but previously 10 SIL procedures had been postulated [41] . However, it is a fair assumption that a competent laparoscopic colorectal surgeon starting out with SIL surgery may well have an initially longer procedure time, with some cost implications.
Conclusion
This study confirms that SIL colorectal surgery is feasible and does not show compromised short-term outcomes compared with the CL approach. The study suggests that SIL is a valid alternative that can be offered by experienced laparoscopic surgeons to most patients eminently suitable for a CL resection. However, while the lack of difference in clinical outcomes in this study failed to determine adequate primary end-points to power a larger trial, available evidence in the literature seems to suggest that postoperative pain is a suitable outcome. Subtle differences in the shortterm outcomes, oncological quality and safety in a general patient and surgeon population will also need to be examined. Uptake of SIL colorectal surgery should be done embedded within a system of quality assurance and audit of outcome against CL as the benchmark.
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